Katsuya Suzuki Selected Research

N-feruloylserotonin

11/2010	Effects of safflower seed extract on arterial stiffness.
11/2009	Safflower seed polyphenols (N-(p-coumaroyl)serotonin and N-feruloylserotonin) ameliorate atherosclerosis and distensibility of the aortic wall in Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katsuya Suzuki Research Topics

Disease

24	Rheumatoid Arthritis 07/2022 - 01/2006
9	Immunoglobulin G4-Related Disease 07/2022 - 09/2015
9	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2016
7	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 09/2003
6	Inflammation (Inflammations) 10/2021 - 02/2009
3	Vasculitis (Vasculitides) 07/2022 - 01/2021
3	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2021 - 01/2021
3	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021 - 01/2020
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2019 - 01/2018
3	Body Weight (Weight, Body) 01/2018 - 06/2015
3	Rheumatic Diseases (Rheumatism) 06/2016 - 01/2009
2	COVID-19 01/2022 - 01/2021
2	Alzheimer Disease (Alzheimer's Disease) 10/2021 - 01/2020
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2021 - 01/2020
2	Lymphadenopathy 01/2021 - 01/2016
2	Systemic Scleroderma (Systemic Sclerosis) 01/2021 - 01/2020
2	Mixed Connective Tissue Disease (MCTD) 01/2021 - 02/2015
2	Synovitis 10/2019 - 02/2016
2	Sialadenitis 04/2016 - 09/2010
2	Obesity 01/2016 - 01/2011
2	Arthritis (Polyarthritis) 05/2015 - 06/2011
2	Atherosclerosis 11/2009 - 07/2006
1	Psoriatic Arthritis 07/2022
1	Breakthrough Infections 01/2022
1	Tauopathies 10/2021
1	Malnutrition (Nutritional Deficiencies) 10/2021
1	Gliosis 10/2021
1	Atrophy 10/2021
1	Pleural Effusion (Pleural Effusions) 07/2021
1	Chylothorax 07/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2021
1	Pleurisy (Pleuritis) 07/2021
1	Polyarteritis Nodosa (Periarteritis Nodosa) 01/2021
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2021

Drug/Important Bio-Agent (IBA)

9	Immunoglobulin G (IgG)IBA 07/2022 - 09/2015
8	GlucocorticoidsIBA 01/2021 - 01/2009
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2015
6	Proteins (Proteins, Gene)FDA Link 10/2021 - 05/2005
6	tocilizumab (atlizumab)FDA Link 01/2020 - 10/2015
5	InterleukinsIBA 01/2022 - 07/2018
5	C-Reactive ProteinIBA 01/2021 - 09/2009
5	Messenger RNA (mRNA)IBA 01/2020 - 09/2003
5	Methotrexate (Mexate)FDA LinkGeneric 10/2019 - 06/2016
5	Infliximab (Remicade)FDA Link 06/2016 - 01/2006
4	Essential Amino AcidsIBA 10/2021 - 06/2015
4	Interleukin-6 (Interleukin 6)IBA 10/2019 - 05/2015
4	Adalimumab (Humira)FDA Link 01/2019 - 09/2016
4	Serotonin (5 Hydroxytryptamine)IBA 11/2010 - 07/2006
3	Amino Acids FDA Link 10/2021 - 01/2016
3	AntibodiesIBA 01/2021 - 01/2020
3	Pharmaceutical PreparationsIBA 01/2021 - 02/2013
3	AutoantibodiesIBA 01/2021 - 02/2015
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 01/2020
3	CytokinesIBA 10/2019 - 10/2015
3	Biological ProductsIBA 01/2016 - 09/2009
3	Leucine (L-Leucine)FDA Link 01/2016 - 05/2015
2	RNA (Ribonucleic Acid)IBA 07/2022 - 01/2022
2	Neutralizing AntibodiesIBA 01/2022 - 01/2021
2	Prednisolone (Predate)FDA LinkGeneric 07/2021 - 01/2009
2	Rituximab (Mabthera)FDA Link 07/2021 - 01/2018
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020 - 10/2017
2	Interleukin-10 (Interleukin 10)IBA 10/2019 - 02/2017
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 10/2019 - 05/2018
2	Tumor Necrosis Factor InhibitorsIBA 01/2019 - 01/2016
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2016 - 06/2011
2	Glycoproteins (Glycoprotein)IBA 01/2016 - 05/2015
2	Muscle Proteins (Muscle Protein)IBA 01/2016 - 06/2015
2	Interleukin-4 (Interleukin 4)IBA 09/2015 - 09/2010
2	Tacrolimus (Prograf)FDA LinkGeneric 06/2011 - 02/2009
2	N-(p-coumaroyl)serotoninIBA 11/2010 - 11/2009
2	N-feruloylserotoninIBA 11/2010 - 11/2009
2	LDL Lipoproteins (beta Lipoproteins)IBA 11/2010 - 07/2006
2	PolyphenolsIBA 11/2010 - 11/2009
2	oxidized low density lipoproteinIBA 11/2010 - 07/2006
2	3' Untranslated Regions (3' UTR)IBA 03/2008 - 01/2006
2	zeta chain antigen T cell receptor (TCR zeta chain)IBA 03/2005 - 09/2003
2	T-Cell Antigen Receptor-CD3 ComplexIBA 03/2005 - 09/2003
1	InterferonsIBA 01/2022
1	Dietary ProteinsIBA 10/2021
1	KynurenineIBA 10/2021
1	Retinaldehyde (Retinal)IBA 07/2021
1	AntigensIBA 01/2021
1	ProcalcitoninIBA 01/2021
1	anticentromere antibodyIBA 01/2021
1	milk fat globuleIBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	IntegrinsIBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	interleukin-21 (interleukin 21)IBA 01/2021
1	HLA-DR Antigens (HLA-DR)IBA 01/2021
1	Rheumatoid FactorIBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	Antirheumatic Agents (DMARD)IBA 01/2021
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 01/2021

Therapy/Procedure

6	Therapeutics 12/2021 - 09/2009
2	Aftercare (After-Treatment) 05/2018 - 05/2015
2	Catheter Ablation 01/2016 - 02/2013
1	Protein-Restricted Diet (Diet, Protein Restricted) 10/2021